Case Report: Anlotinib Combined with PD-1 Inhibitor and Sequential GA Regimen or FOLFIRINOX Chemotherapy in Treatment of KRAS G12V Mutated Pancreatic Ductal Adenocarcinoma with Liver Metastasis: A Case and Literature Review
Frontiers in Immunology（2022）
Key words
Anlotinib,PD-1 inhibitor,chemotherapy,metastatic pancreatic ductal adenocarcinoma,KRAS,case report
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined